Does neoadjuvant therapy improve survival in pancreatic adenocarcinoma?

被引:1
|
作者
Chopra, Asmita [1 ]
Paniccia, Alessandro [1 ]
机构
[1] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA USA
关键词
D O I
10.21037/hbsn-21-250
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:728 / 730
页数:3
相关论文
共 50 条
  • [21] Survival outcomes of conversion surgery for metastatic pancreatic ductal adenocarcinoma after neoadjuvant therapy
    Zhu Lingyu
    Gao Suizhi
    Wu Xinqian
    Li Bo
    Shi Xiaohan
    Yin Xiaoyi
    Wang Huan
    Shi Meilong
    Li Penghao
    Li Yikai
    Zhong Chaoliang
    Teng Chuanqi
    Han Jiawei
    Ren Yiwei
    Wang Jian
    Fu Zhendong
    Liu Xinyu
    Zheng Kailian
    Guo Shiwei
    Jin Gang
    [J]. 胰腺病学杂志(英文), 2023, 06 (03)
  • [22] Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
    Theodoros Michelakos
    Yurie Sekigami
    Filippos Kontos
    Carlos Fernández-del Castillo
    Motaz Qadan
    Vikram Deshpande
    David T. Ting
    Jeffrey W. Clark
    Colin D. Weekes
    Aparna Parikh
    David P. Ryan
    Jennifer Y. Wo
    Theodore S. Hong
    Jill N. Allen
    Onofrio Catalano
    Andrew L. Warshaw
    Keith D. Lillemoe
    Cristina R. Ferrone
    [J]. Journal of Gastrointestinal Surgery, 2021, 25 : 2859 - 2870
  • [23] Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
    Cooper, Amanda B.
    Parmar, Abhishek D.
    Riall, Taylor S.
    Hall, Bruce L.
    Katz, Matthew H. G.
    Aloia, Thomas A.
    Pitt, Henry A.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (01) : 80 - 87
  • [24] Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
    Cooper, Amanda
    Parmar, Abhishek
    Hall, Bruce L.
    Katz, Matthew H.
    Fleming, Jason B.
    Aloia, Thomas
    Riall, Taylor S.
    Pitt, Henry
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S1016 - S1016
  • [25] Prognostic Value and Survival of Positive-Margin Resections for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy
    Al Abbas, Amr I.
    Meier, Jennie
    Ju, Michelle
    Abreu, Andres A.
    Porembka, Matthew R.
    Wang, Sam C.
    Augustine, Mathew M.
    Yopp, Adam C.
    Zeh, Herbert J., III
    Polanco, Patricio M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S461 - S461
  • [26] NEOADJUVANT THERAPY-INDUCED SARCOPENIA IS ASSOCIATED WITH DECREASED OVERALL SURVIVAL IN PANCREATIC DUCTAL ADENOCARCINOMA
    Sell, Naomi M.
    Fernandez-del Castillo, Carlos
    Ferrone, Cristina R.
    Lillemoe, Keith
    Hank, Thomas P.
    Weekes, Colin D.
    Torriani, Martin
    Buckless, Colleen G.
    Silver, Julie K.
    Fintelmann, Florian J.
    Qadan, Motaz
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1527 - S1528
  • [27] GASTRIC ADENOCARCINOMA - DOES CHEMOTHERAPY IMPROVE SURVIVAL
    CUNNINGHAN, D
    HOLE, D
    TAGGART, DJ
    CARTER, DC
    SOUKOP, M
    MCARDLE, CS
    [J]. BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 202 - 202
  • [28] Pathological complete response after neoadjuvant therapy for pancreatic ductal adenocarcinoma does not equal cure
    Zhou, Yanming
    Liao, Shan
    You, Jun
    [J]. ANZ JOURNAL OF SURGERY, 2021, 91 (05) : E254 - E259
  • [29] Association of Adjuvant Chemotherapy with Overall Survival in Resected Pancreatic Adenocarcinoma Previously Treated with Neoadjuvant Therapy
    Swords, D. S.
    Garrido-Laguna, I.
    Mulvihill, S. J.
    Stoddard, G. J.
    Firpo, M. A.
    Scaife, C. L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S116 - S116
  • [30] Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach?
    Niek A. Peters
    Ammar A. Javed
    John L. Cameron
    Martin A. Makary
    Kenzo Hirose
    Timothy M. Pawlik
    Jin He
    Christopher L. Wolfgang
    Matthew J. Weiss
    [J]. Annals of Surgical Oncology, 2016, 23 : 3757 - 3764